Silva Pharmaceuticals Limited (DSE:SILVAPHL)
8.90
-0.50 (-5.32%)
At close: Mar 8, 2026
Silva Pharmaceuticals Market Cap
Silva Pharmaceuticals has a market cap or net worth of 1.24 billion as of March 9, 2026. Its market cap has decreased by -2.15% in one year.
Market Cap
1.24B
Enterprise Value
1.16B
Revenue
356.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.90
Market Cap Chart
Since October 10, 2018, Silva Pharmaceuticals's market cap has decreased from 3.77B to 1.24B, a decrease of -67.05%. That is a compound annual growth rate of -13.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advent Pharma | 1.23B |
| Silco Pharmaceuticals | 1.35B |
| Libra Infusions | 1.41B |
| Indo-Bangla Pharmaceuticals | 1.52B |
| Central Pharmaceuticals | 1.02B |
| Pharma Aids | 1.69B |
| Ambee Pharmaceuticals | 1.79B |
| Techno Drugs | 3.87B |